TELA Bio (TELA) Net Cash Flow (2018 - 2026)

TELA Bio has reported Net Cash Flow for 9 years, with the latest figure at -$9.2 million in Q2 2026.

• On a quarterly basis, Net Cash Flow fell 18.86% year-over-year to -$9.2 million in Q2 2026; TTM through Jun 2026 was -$4.7 million, a 153.01% decrease from a year earlier, with the FY2025 full-year figure at -$1.6 million, down 127.45% from the prior year.
• Net Cash Flow was -$9.2 million for Q2 2026 at TELA Bio, up from -$11.3 million in the prior quarter.
• The five-year high for Net Cash Flow was $35.2 million in Q4 2024, with the low at -$12.2 million in Q4 2022.
• Average Net Cash Flow over 5 years is -$727888.9, with a median of -$9.1 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Net Cash Flow surged 767.96% in 2023, then slumped 130.4% in 2024.
• Over 5 years, Net Cash Flow stood at -$12.2 million in 2022, then grew by 8.38% to -$11.2 million in 2023, then surged by 413.55% to $35.2 million in 2024, then plunged by 39.84% to $21.2 million in 2025, then plunged by 143.26% to -$9.2 million in 2026.
• The last three Net Cash Flow figures came in at -$9.2 million (Q2 2026), -$11.3 million (Q1 2026), and $21.2 million (Q4 2025), per Business Quant data.